Nasdaq: GLSI
Greenwich LifeSciences insiders
The officers, directors and 10% owners of Greenwich LifeSciences, Inc. who hold the most stock, valued at the live GLSI price.
$19.79
GLSI today −$790K (−3.84%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their GLSI stock
- $136M
- Market value
- $290M
- Held by ranked insiders
- 47.0%
Insiders by value of GLSI holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Snehal Patel | CEO and CFO | 5,611,402 | $111M | 38.2% | 1396th |
| 2 | David McWilliams | Director | 620,301 | $12.3M | 4.23% | 7529th |
| 3 | Kenneth Hallock | Director | 397,304 | $7.9M | 2.71% | 10494th |
| 4 | Jaye Thompson | VP Clinical Reg Affairs | 264,148 | $5.2M | 1.80% | 14026th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Greenwich LifeSciences; see each profile for the filing.